ESPR vs. ARKF
ESPR (Esperion Therapeutics, Inc.) is a stock, while ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK. Over the past 5 years, ESPR returned -32.81%/yr vs -6.28%/yr for ARKF. At a 0.28 correlation, their price movements are largely independent.
Performance
ESPR vs. ARKF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESPR achieves a -14.59% return, which is significantly higher than ARKF's -18.35% return.
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.59%
- 6M
- -18.56%
- 1Y
- 203.85%
- 3Y*
- 33.44%
- 5Y*
- -32.81%
- 10Y*
- -15.04%
ARKF
- 1D
- -1.37%
- 1M
- -4.80%
- YTD
- -18.35%
- 6M
- -20.79%
- 1Y
- -19.31%
- 3Y*
- 24.85%
- 5Y*
- -6.28%
- 10Y*
- —
ESPR vs. ARKF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | -14.59% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 28.68% |
ARKF ARK Fintech Innovation ETF | -18.35% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 20.45% |
Correlation
The correlation between ESPR and ARKF is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESPR vs. ARKF — Risk / Return Rank
ESPR
ARKF
ESPR vs. ARKF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESPR | ARKF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.81 | ||
| Sortino ratioReturn per unit of downside risk | +3.84 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 0.93 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 3.86 | -0.50 | +4.36 |
| Martin ratioReturn relative to average drawdown | 9.56 | -0.90 | +10.46 |
Loading charts...
Drawdowns
ESPR vs. ARKF - Drawdown Comparison
The maximum ESPR drawdown since its inception was -99.37%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for ESPR and ARKF.
Loading charts...
Drawdown Indicators
| ESPR | ARKF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -78.63% | -20.74% |
Max Drawdown (1Y)Largest decline over 1 year | -53.19% | -38.50% | -14.69% |
Max Drawdown (3Y)Largest decline over 3 years | -80.94% | -38.50% | -42.44% |
Max Drawdown (5Y)Largest decline over 5 years | -96.92% | -75.30% | -21.62% |
Max Drawdown (10Y)Largest decline over 10 years | -99.10% | — | — |
Current DrawdownCurrent decline from peak | -97.26% | -38.80% | -58.46% |
Average DrawdownAverage peak-to-trough decline | -70.04% | -34.96% | -35.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.42% | 21.58% | -0.16% |
Volatility
ESPR vs. ARKF - Volatility Comparison
The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.33%, while ARK Fintech Innovation ETF (ARKF) has a volatility of 10.86%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESPR | ARKF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.33% | 10.86% | -9.53% |
Volatility (6M)Calculated over the trailing 6-month period | 60.63% | 25.24% | +35.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.25% | 33.47% | +58.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.79% | 42.93% | +48.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.52% | 39.75% | +44.77% |
Dividends
ESPR vs. ARKF - Dividend Comparison
ESPR has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ESPR and ARKF have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKF has higher volatility (10.86%) compared to ESPR (1.33%). In terms of maximum drawdown, ESPR dropped -99.37% vs ARKF's -78.63%.
ESPR currently has the higher Sharpe Ratio (2.23 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESPR and ARKF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer